Edward T. Anderson, Director, 10% Owner at Lyra Therapeutics, Inc. (LYRA), bought 946,284 shares at $16.00 ($4.4M) on 2020-05-05, disclosed to the SEC on 2020-05-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 651,453 | $0 | 0.0% |
| 2 | $8.63 | 10,322 | $89K | 2.0% |
| 3 | $8.63 | 13,449 | $116K | 2.6% |
| 4 | $8.63 | 21,060 | $182K | 4.1% |
| 5 | $16.00 | 57,561 | $921K | 21.0% |
| 6 | $16.00 | 75,000 |
| $1.2M |
| 27.4% |
| 7 | $16.00 | 117,439 | $1.9M | 42.8% |
| Total | $4.64 avg | 946,284 | $4.4M | 100% |
| Filing → |
| LYRA | BUY | 2022-04-14 | $21.0M | — | Filing → |
| BASE | BUY | 2021-07-26 | $4.0M | — | Filing → |
| PRLB | SELL | 2013-02-25 | $22K | — | Filing → |